# US 2025/0017806 A1 · Diagnostic and therapeutic splints and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0017806 A1
- Document ID: US20250017806A1
- Status: Published application
- Kind: A1
- Application number: 18/813,159
- Filed: 2024-08-23
- Published: 2025-01-16
- Earliest claimed: 2020-04-17
- Assignees: The Florida State University Research Foundation, Inc.
- Applicants: The Florida State University Research Foundation, Inc.
- Inventors: Emily Pritchard; Mina-Michael Barsoum; Judy Delp; Joshua Maraj
- Web page: https://patentgrep.com/patent/US20250017806A1

## CPC

- A61H 1/0266: {Foot}
- A61B 5/0075: {by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence)}
- A61B 5/14551: {for measuring blood gases}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 2503/08: Elderly
- A61B 2505/09: Rehabilitation or training
- A61H 2001/0207: {Nutating movement of a body part around its articulation}
- A61H 2201/0103: inflatable
- A61H 2201/1238: with hydraulic or pneumatic drive
- A61H 2201/1253: driven by a human being, e.g. hand driven
- A61H 2201/1642: Holding means therefor
- A61H 2201/165: Wearable interfaces
- A61H 2201/1671: rotational
- A61H 2201/1676: Pivoting
- A61H 2203/0437: with stretched legs, like in a bed
- A61H 2205/106: for the lower legs
- A61H 2205/12: Feet
- A61H 2209/00: Devices for avoiding blood stagnation, e.g. Deep Vein Thrombosis [DVT] devices
- A61H 2230/207: partial O2-value
- A61H: PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY (electrotherapy, magnetotherapy, radiation therapy or ultrasound therapy A61N)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Various implementations include a method of decreasing oxygen saturation levels in a patient, including securing a leg and foot of the patient to a splint having a leg supporting portion, a foot supporting portion, and an inflatable device. The leg supporting portion includes a leg support body and leg support surface. The foot supporting portion includes a foot support body and foot support surface. The inflatable device rotates the foot support surface relative to the leg support surface from a first position to a second position. The angle between a leg longitudinal axis and a foot longitudinal axis is less in the second position than in the first position. The method further includes inflating the inflatable device to rotate the foot support surface from the first position to the second position and maintaining the second position to decrease oxygen saturation levels in the patient.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A splint for diagnostic and/or therapeutic functions for a patient with a vascular impairment, the splint comprising:
a leg supporting portion comprising a leg support body, the leg support body comprising (i) a first rigid shell having an inner surface and (ii) an inner liner coupled to the inner surface of the inner surface of the first rigid shell to define a leg support surface, the leg support surface being configured to support and secure a leg of the patient, the leg support surface having a leg longitudinal axis;
a foot supporting portion comprising a foot support body, the foot support body comprising (i) a second rigid shell having an inner surface, (ii) an insole coupled to the inner surface of the second rigid shell to define a foot support surface, the foot support surface being configured to support and secure a portion of a foot of the patient, the foot support surface having a foot longitudinal axis, and (iii) a bladder disposed between the insole and the inner surface of the second rigid shell;
one or more straps spanning between the leg supporting portion and the foot supporting portion configured to maintain the foot longitudinal axis at a fixed acute angle with respect to the leg longitudinal axis in a first position; and
a pump removably coupled to and in fluid communication with the bladder of the foot supporting portion, the pump and the bladder together configured for rotating the foot support surface relative to the leg support surface from the first position to a second position, wherein an angle between the leg longitudinal axis and the foot longitudinal axis is less in the second position than in the first position.

### Claim 22 (depends on 21)

The splint of claim 21, wherein the angle between the leg longitudinal axis and the foot longitudinal axis in the second position is a verified angle for inducing an ischemic condition in the patient, the verified angle being preconfigured based on a first length of the one or more straps, a first oxygen saturation level of the patient, and inflation of the bladder via the pump.

### Claim 23 (depends on 21)

The splint of claim 21, wherein the angle in the second position is less than the angle in the first position by a difference of 2 degrees or more.

### Claim 24 (depends on 21)

The splint of claim 21, wherein the angle in the first position is 70 degrees or greater.

### Claim 25 (depends on 21)

The splint of claim 21, wherein the angle in the second position is 68 degrees or greater.

### Claim 26 (depends on 21)

The splint of claim 21, wherein the angle in the second position is in a range of 68 degrees to 73 degrees.

### Claim 27 (depends on 21)

The splint of claim 21, wherein the one or more straps are coupled to each of the first rigid shell of the leg supporting portion and the second rigid shell of the foot supporting portion.

### Claim 28 (depends on 21)

The splint of claim 21, wherein the first rigid shell of the leg supporting portion and the second rigid shell of the foot supporting portion are integrally formed with each other to define a continuous rigid shell of the splint.

### Claim 29 (depends on 21)

The splint of claim 21, wherein the pump further comprises a releasable one-way valve to selectively prevent backflow of air from the bladder.

### Claim 30 (depends on 29)

The splint of claim 29, wherein the releasable one-way valve is movable to a second position to allow backflow of air from the bladder to a surrounding environment.

### Claim 31

A method of decreasing oxygen saturation levels in a patient, the method comprising:
securing a leg and foot of the patient to a splint for diagnostic and/or therapeutic functions for the patient with a vascular impairment, the splint comprising:
a leg supporting portion comprising a leg support body, the leg support body comprising (i) a first rigid shell having an inner surface and (ii) an inner liner coupled to the inner surface of the inner surface of the first rigid shell to define a leg support surface, the leg support surface being configured to support and secure a leg of the patient, the leg support surface having a leg longitudinal axis;
a foot supporting portion comprising a foot support body, the foot support body comprising (i) a second rigid shell having an inner surface, (ii) an insole coupled to the inner surface of the second rigid shell to define a foot support surface, the foot support surface being configured to support and secure a portion of a foot of the patient, the foot support surface having a foot longitudinal axis, and (iii) a bladder disposed between the insole and the inner surface of the second rigid shell;
one or more straps spanning between the leg supporting portion and the foot supporting portion configured to maintain the foot longitudinal axis at a fixed acute angle with respect to the leg longitudinal axis in a first position; and
a pump removably coupled to and in fluid communication with the bladder of the foot supporting portion, the pump and the bladder together configured for rotating the foot support surface relative to the leg support surface from the first position to a second position;
actuating the pump to inflate the bladder and rotate the foot support surface from the first position to the second position, wherein an angle between the leg longitudinal axis and the foot longitudinal axis is less in the second position than in the first position; and
maintaining the foot support surface in the second position to decrease oxygen saturation levels in the patient.

### Claim 32 (depends on 31)

The method of claim 31, wherein the angle between the leg longitudinal axis and the foot longitudinal axis in the second position is a verified angle for inducing an ischemic condition in the patient, the verified angle being preconfigured based on a first length of the one or more straps, a first oxygen saturation level of the patient, and inflation of the bladder via the pump.

### Claim 33 (depends on 31)

The method of claim 31, wherein the angle in the second position is less than the angle in the first position by a difference of 2 degrees or more.

### Claim 34 (depends on 31)

The method of claim 31, wherein the angle in the first position is 70 degrees or greater.

### Claim 35 (depends on 31)

The method of claim 31, wherein the angle in the second position is 68 degrees or greater.

### Claim 36 (depends on 31)

The method of claim 31, wherein the angle in the second position is in a range of 68 degrees to 73 degrees.

### Claim 37 (depends on 31)

The method of claim 31, further comprising maintaining the foot support surface in the second position until the oxygen saturation level of the patient is 74.6% or less.

### Claim 38 (depends on 31)

The method of claim 31, further comprising maintaining the foot support surface in the second position for 10 minutes or more.

### Claim 39 (depends on 31)

The method of claim 31, further comprising straightening a knee of the leg of the patient while the patient is in an upright seated position prior to remaining in the second position.

### Claim 40 (depends on 31)

The method of claim 31, further comprising administering a supplement to the patient after inflating the bladder.
